''Glioblast licensed the compound from Roche’s Genentech.
Who is Glioblast? I’m glad you asked — and goodness, it’s a very small biotech world.
The Sydney company was owned by Viralytics chairman Paul Hopper (Genentech’s former program leader for GDC-0084) and Leslie Chong, now Imugene’s CEO.''
Why would Genentechs former program leader for GDC0084 sell his holding at the first opportunity when his shares came out of escrow ?
https://unauthorised investment advice/health/kazia-wants-to-cure-the-disease-that-delivered-the-trump-presidency/
DYOR
